Conseil de prévention et de lutte contre le dopage

The Lutte contre le Agence Française de Dopage ( AFLD ) (from the French: " Agency for the fight against doping ," originally Conseil de Lutte contre le Prévention et de Dopage ) is the French Anti -Doping Agency, based in Paris. President of the AFLD to 30 September 2010 was Pierre Bordry.

The controls are the AFLD by Laboratoire National de dépistage you Dopage performed ( LNDD ) ( "National laboratory for detection of doping "). It was in 1966, because of a new French law, established against the use of stimulants in sport and is in Chatenay -Malabry since 1989. 2009 10 000 analyzes was performed.

Detection of EPO

In 2000, a method for the detection of erythropoietin (EPO ) has been developed in urine from LNDD. This has been used, among others, to analyze samples of cyclists in the Tour de France 1999 in retrospect. Here, according to media reports, some athletes were tested positive, including Lance Armstrong, but without sanctions were adopted. Armstrong himself as well as many experts and cycling officials accused the AFLD in this context, massive defects in the processing of the samples and in dealing with the confidentiality of the driver data before and spoke of a "witch hunt ".

No exceptions

One of the World Anti -Doping Agency (WADA ) developed a new method for Exemption of banned substances for therapeutic healing (TUE ) is not accepted by the AFLD.

Tour de France

In June 2010 Bordry criticized the doping controls at the Tour de France. Be predictable and inefficient. For this he was sharply attacked by the President of the International Cycling Union Pat McQuaid. He also demanded Bordrys detachment. As a consequence of the doping test at the Tour de France will be monitored in 2010 by independent observers WADA. A request by the AFLD to make their own tests, was rejected by the WADA.